Jefferies Group LLC Grifols Sa Transaction History

Jefferies Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $947,951 - $1.49 Million	-58,228 Reduced 20.12%	231,230 $4.63 Million
Q4 2019 Feb 13, 2020	SELL	$19.57 - $23.52 $716,575 - $861,208	-36,616 Reduced 11.23%	289,458 $6.71 Million
Q3 2019 Nov 13, 2019	BUY	$19.85 - $22.76 $5.3 Million - $6.07 Million	266,877 Added 450.83%	326,074 $6.54 Million
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $785,956 - $942,790	44,682 Added 307.83%	59,197 $1.25 Million
Q1 2019 May 15, 2019	SELL	$18.01 - $20.11 $842,543 - $940,786	-46,782 Reduced 76.32%	14,515 $292,000
Q4 2018 Feb 14, 2019	BUY	$17.44 - $21.53 $796,938 - $983,834	45,696 Added 292.9%	61,297 $1.13 Million
Q3 2018 Nov 14, 2018	BUY	$19.97 - $21.96 $311,551 - $342,597	15,601 New	15,601 $333,000
Q2 2018 Aug 14, 2018	SELL	$20.16 - $24.68 $888,793 - $1.09 Million	-44,087 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$20.31 - $24.95 $338,709 - $416,091	-16,677 Reduced 27.45%	44,087 $935,000
Q4 2017 Feb 14, 2018	BUY	$20.99 - $23.89 $1.28 Million - $1.45 Million	60,764	60,764 $1.39 Million

147

151M

2.38M

662K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.57B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.